Why we took Alzheimer's disease as a primary focus
In the United States alone, Alzheimer’s prevalence is estimated to affect 6 million people, with the rate increasing to 19% in the 75–84 age group and 42% in people over 84 years of age.
Currently, there is no drug or vaccine that has shown substantial results in the fight against Alzheimer’s.
Nobody really knows the reasons, but extensive studies have demonstrated that beta-amyloid and tau always play a negative role in AD development.
The disease starts developing when people are 40-50 years old with no obvious signs.